Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real‐life study. (18th February 2022)

Record Type:: Journal Article
Title:: Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real‐life study. (18th February 2022)
Main Title:: Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real‐life study
Authors:: Velin, M.
Dugourd, P.‐M.
Sanchez, A.
Bahadoran, P.
Montaudié, H.
Passeron, T.
Abstract:
Is Part Of:: Journal of the European Academy of Dermatology and Venereology. Volume 36:Number 7(2022)
Journal:: Journal of the European Academy of Dermatology and Venereology
Issue:: Volume 36:Number 7(2022)
Issue Display:: Volume 36, Issue 7 (2022)
Year:: 2022
Volume:: 36
Issue:: 7
Issue Sort Value:: 2022-0036-0007-0000
Page Start:: e539
Page End:: e542
Publication Date:: 2022-02-18
Subjects:: Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5
Journal URLs:: https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗
DOI:: 10.1111/jdv.17999 ↗
Languages:: English
ISSNs:: 0926-9959
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 22640.xml